POWIS GARTH has a total of 14 patent applications. Its first patent ever was published in 1997. It filed its patents most often in United States, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are IONIX PHARMACEUTICALS LTD, LANKENAU INST MEDICAL RES and SHANXI YABAO PHARMACEUTICAL GROUP CORP.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | WIPO (World Intellectual Property Organization) | 5 | |
#3 | Canada | 1 | |
#4 | EPO (European Patent Office) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement | |
#4 | Biotechnology | |
#5 | Micro-structure and nano-technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Heterocyclic compounds | |
#4 | Analysing materials | |
#5 | Nanostructure applications | |
#6 | Microorganisms | |
#7 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Powis Garth | 14 |
#2 | Wipf Peter | 3 |
#3 | Kirkpatrick Lynn | 2 |
#4 | Cherukuri Paul | 1 |
#5 | Bartholomeusz Jeffrey | 1 |
#6 | Tour James | 1 |
#7 | Gillies Robert J | 1 |
#8 | Herbst Roy | 1 |
#9 | Weisman R Bruce | 1 |
#10 | Schmidt Howard | 1 |
Publication | Filing date | Title |
---|---|---|
US2009131511A1 | Palmarumycin based inhibitors of thioredoxin and methods of using same | |
CA2274116A1 | Use, of an inhibitor of thioredoxin, for inhibiting tumor growth |